Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
Collaboration matches more eligible patients, including those with rare and complex diseases, to appropriate clinical trials
Pete Pharma will leverage FABRX’s extensive foundation of scientific validation to deliver a commercially viable, pharmacy-ready solution in the US
IND application for EB-003 expected in early 2026
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
Element5’s Agentic AI platform will be integrated with the HCHB EHR
Philips and Masimo will also collaborate on the development and co-promotion of next-generation monitoring solutions
AHLL will become a 100% subsidiary of AHEL with 99.42% held by AHEL and balance in the ESOP pool
Subscribe To Our Newsletter & Stay Updated
